Lexington, KY and San Antonio, TX – Biomedical Development Corporation (BDC) of San Antonio, Texas will expand its operations to Lexington. The 28 year-old company has secured two grants from the Kentucky SBIR-STTR Matching Funds Program.
Aligned with the grant program and the University of Kentucky, BDC’s Kentucky operations will focus on two initiatives: a mouth rinse that fights oral inflammation and a patient management software designed to better understand and treat bipolar disorder.
“The State of Kentucky has provided some very forward-thinking financial and programming incentives for Biomedical to move here because of the commercial potential of our products and the expertise of the company,” said Company founder and CEO Phyllis Siegel in a company statement. “We are meeting members of an open and progressive startup community and look forward to being part of the regional ecosystem.”
Upcoming Clinical Trial for New Oral Mouth Rinse
The mouth rinse will be tested in an upcoming trial in collaboration with the Center for Oral Health Research at the University of Kentucky. The mouth rinse is a unique product because it fights oral inflammation and may lower high cholesterol, according to the company. It has been previously tested in three human clinical trials. The fourth trial will begin in January 2013. This research is funded by the National Heart, Lung, and Blood Institute.